LIMES Schlosskliniken AG (ETR:LIK)
525.00
+27.00 (5.42%)
Jun 19, 2026, 5:37 PM CET
LIMES Schlosskliniken AG Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, LIMES Schlosskliniken AG stock has a consensus rating of "Strong Buy" and an average price target of €647.50. The average 1-year stock price forecast is 23.33% higher than the current stock price, while the lowest is €585.00 (+11.43%) and the highest is €710.00 (+35.24%).
Price Target: €647.50 (+23.33%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LIMES Schlosskliniken AG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Dec '25 | Feb '26 | Mar '26 | Apr '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
67.30M
from 50.00M
Increased by 34.61%
Revenue Next Year
79.07M
from 67.30M
Increased by 17.50%
EPS This Year
35.60
from 19.11
Increased by 86.29%
EPS Next Year
45.54
from 35.60
Increased by 27.92%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 67.3M | ||
| Avg | 67.3M | ||
| Low | 67.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 34.6% | ||
| Avg | 34.6% | ||
| Low | 34.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 35.60 | ||
| Avg | 35.60 | ||
| Low | 35.60 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 86.3% | ||
| Avg | 86.3% | ||
| Low | 86.3% |